Charles Schwab Investment Management Inc. Sells 525,408 Shares of bluebird bio, Inc. (NASDAQ:BLUE)
Charles Schwab Investment Management Inc. reduced its holdings in bluebird bio, Inc. (NASDAQ:BLUE – Free Report) by 95.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 27,652 shares of the biotechnology company’s stock after selling 525,408 shares during the period. Charles Schwab Investment Management […]
